肾上腺素、利多卡因和丙胺卡因对人脂肪干细胞活力和分化能力的影响
体外研究分析丙胺卡因或利多卡因与肾上腺素联合暴露对人原代脂肪干细胞活力(增殖、代谢活性、细胞毒性)及分化的影响。2小时后丙胺卡因(10 mM)显著降低代谢活性和细胞数,利多卡因仅抑制代谢活性;6小时后两者均显著降低代谢活性和细胞数。高浓度肾上腺素不影响细胞数但降低代谢活性,利多卡因联合肾上腺素无额外细胞毒性,肾上腺素显著抑制软骨分化。作者认为在肿胀麻醉等效浓度下,利多卡因联合肾上腺素或丙胺卡因对脂肪干细胞无细胞毒性,对成骨和成脂分化能力无长期影响。
要点
- 2小时后丙胺卡因(10 mM)显著降低代谢活性和细胞数,利多卡因仅抑制代谢活性。
- 6小时后丙胺卡因(10 mM)和利多卡因均显著降低代谢活性和细胞数。
- 高浓度肾上腺素不影响细胞数但降低代谢活性,显著抑制软骨分化。
核心结论
- 作者根据数据推断,在肿胀麻醉等效浓度下,利多卡因联合肾上腺素或丙胺卡因在体外对脂肪干细胞无细胞毒性,且对成骨和成脂分化能力无长期影响。
研究设计与样本
- 体外研究分析丙胺卡因或利多卡因与肾上腺素联合暴露对人原代脂肪干细胞的活力(增殖、代谢活性、细胞毒性)及分化的影响。
主要发现
- 2小时后,丙胺卡因(10 mM)显著降低代谢活性和细胞数,而利多卡因仅抑制代谢活性。
- 6小时后,丙胺卡因(10 mM)和利多卡因均显著降低代谢活性和细胞数。
- 高浓度肾上腺素不影响细胞数但降低代谢活性。
- 利多卡因联合肾上腺素无额外细胞毒性效应。
- 肾上腺素显著抑制向软骨谱系的分化。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Local anesthetics (LAs) are routinely administered in plastic and reconstructive surgery, e.g., as tumescent anesthesia adjunct in liposuction. Historically, these substances were assumed to act cytotoxically. Thus, the application of LA was avoided when handling adipose stem cells (ASCs). We recently determined that most LAs are not cytotoxic when ASCs are exposed to concentrations used for tumescent liposuction. However, there is limited information when combining LA with epinephrine and about the effects of prilocaine on ASCs. METHODS: We analyzed the effects of prilocaine or lidocaine in co-exposure with epinephrine on the viability of primary human ASCs, i.e., proliferation, metabolic activity, and cytotoxicity, using crystal violet-staining, PrestoBlue®-, and WST-1 assay. We quantified the impact of short-term incubation of lidocaine and epinephrine on the differentiation of ASCs into the adipogenic, chondrogenic, and osteogenic lineage. RESULTS: After 2 h, prilocaine (10 mM) significantly reduced metabolic activity and cell numbers, whereas lidocaine only inhibited metabolic activity. After 6 h, prilocaine (10 mM) and lidocaine significantly decreased metabolic activity as well as cell numbers. The application of high concentrations of epinephrine did not affect cell numbers but diminished metabolic activity. Combining lidocaine with epinephrine had no additional cytotoxic effect. Differentiation into the chondrogenic lineage was significantly inhibited by epinephrine. CONCLUSIONS: Deducing from our data, neither lidocaine combined with epinephrine nor prilocaine has a cytotoxic impact on ASCs in vitro at concentrations equivalent to those in tumescent anesthesia and has no long-lasting effect on the differentiation capacity of ASCs into the osteogenic and adipogenic lineage.
引用
- Guillaume VGJ, Lanckohr LS, Lippold EF, et al. Effects of epinephrine, lidocaine, and prilocaine on viability and differentiation capacity of human adipose stem cells. J Plast Reconstr Aesthet Surg. 2023. PMID: 37939646. doi:10.1016/j.bjps.2023.10.104
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。